Objective is to determine whether orally administered recombinant lactoferrin, produced in Aspergillis awamori, is a safe and effective agent for the treatment of infectious Helicobacter pylori gastritis. Currently 6 patients have been enrolled, and preliminary evidence shows no side effects although no efficacy has yet been determined. Study will continue with higher dosing to further dvaluate efficacy.
Showing the most recent 10 out of 459 publications